David Soergel

David Soergel

Chief Tech/Sci/R&D Officer at MADRIGAL PHARMACEUTICALS, INC.

Net worth: 5 M $ as of 2026-05-30

58 year
Health Technology
Consumer Services

Profile

David Soergel is Chief Medical Officer & Executive Vice President at Madrigal Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Soergel was Senior Director-Clinical Development at Concert Pharmaceuticals, Inc., Director-Discovery Medicine at GlaxoSmithKline LLC, and Chief Medical Officer at Trevena, Inc. in 2015.
Education includes undergraduate studies at The Johns Hopkins University and a doctorate from Cornell University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 10,033 ( 0.04% ) 5 M $ 2026-05-30

David Soergel active positions

CompaniesPositionStart
MADRIGAL PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2025-04-20

Former positions of David Soergel

CompaniesPositionEnd
CONCERT PHARMACEUTICALS, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
TREVENA, INC. Chief Tech/Sci/R&D Officer -
See the detail of David Soergel's experience

Training of David Soergel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology